TLR5 and graft versus host disease: In conclusion, the findings of the present study suggest that TLR5 agonists can affect the activity of NFκB signaling in mesenchymal stem cells, increase the secretion of anti-inflammatory cytokines, and induce their polarization into M2 macrophages, which may induce long-term survival of GVHD models and improve therapeutic efficacy.